CRYOPORT, INC. Shareholders' Equity
CRYOPORT, INC. (CYRX) had Shareholders' Equity of $490.70 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $490.70M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $494.99M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $502.64M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $513.27M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $490.70M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $494.99M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $502.64M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $513.27M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $519.08M 10-Q · filed 2026-08-06 | $515.39M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $398.81M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $401.90M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $418.57M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $400.10M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $472.19M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $489.02M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $537.53M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $544.25M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $560.52M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $555.84M 10-K · filed 2026-03-05 | |
| 2022-09-30 | $555.72M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $568.42M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $609.43M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $641.83M 10-K · filed 2025-03-07 | |
| 2021-09-30 | $647.23M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $648.03M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $647.27M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $382.70M 10-K · filed 2024-03-13 | |
| 2020-09-30 | $120.04M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $126.66M 10-Q · filed 2020-11-06 | |
| 2020-03-31 | $127.30M 10-Q · filed 2020-08-10 | |
| 2019-12-31 | $126.28M 10-K · filed 2021-03-01 | $126.28M 10-K · filed 2020-03-10 |
| 2019-09-30 | $110.33M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $108.75M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $38.91M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $38.55M 10-Q · filed 2020-11-06 | |
| 2018-09-30 | $29.08M 10-Q · filed 2019-11-12 | $29.03M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $24.42M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $22.45M 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $17.89M 10-K · filed 2020-03-10 | |
| 2017-09-30 | $17.75M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $15.03M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $16.07M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $5.68M 10-K · filed 2019-03-13 | |
| 2016-09-30 | $3.70M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.09M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.10M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $4.99M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $6.72M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $2.05M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$416.30K 10-KT · filed 2017-03-13 | |
| 2014-12-31 | -$1.12M 10-Q · filed 2015-02-05 | |
| 2014-09-30 | -$1.37M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$1.06M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | -$2.30M 10-K · filed 2016-06-28 | |
| 2013-12-31 | -$1.40M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | -$577.88K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | -$3.02M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$2.06M 10-K · filed 2015-05-19 | |
| 2012-12-31 | -$550.73K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $776.49K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $2.26M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $3.73M 10-K · filed 2014-06-25 | |
| 2011-12-31 | $620.87K 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $2.50M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $4.09M 10-Q · filed 2011-08-15 | |
| 2011-03-31 | $5.95M 10-K · filed 2013-06-25 | |
| 2010-03-31 | -$914.58K 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |